Phase Ⅱ Clinical Trial of High-Dose Toremifene as Primary Hormone Therapy in Aromatase Inhibitor-Resistant Breast Cancer 緒方秀昭 and ほか, 癌と化学療法, 40, 749-753 (2013), DOI:http://dx.doi.org/